Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases, and preparation method for Chinese medicinal composition

A technology of cardiovascular and cerebrovascular diseases and compositions, applied in the field of medicine, can solve the problems of slow thrombolytic effect and insufficient curative effect of cardiovascular, cerebrovascular and renal vascular diseases, and improve the microcirculation of the heart, brain and kidney, with reliable curative effect and convenient operation Effect

Inactive Publication Date: 2013-12-04
周保民 +2
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, drug therapy (oral or injection) for prevention and treatment of cardiovascular, cerebrovascular and renal vascular diseases mostly adopts drugs for dispelling wind and dredging collaterals, promoting blood circulation and removing blood stasis. Not significant enough

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The raw materials used in this example are 10 g of Panax notoginseng, 10 g of Rhizoma Chuanxiong, 10 g of hippocampus, and 3 g of pangolin.

[0026] The preparation method of the present embodiment is as follows:

[0027] Step 1. Weighing each raw medicinal material, soaking the weighed raw medicinal material with alcohol with a mass concentration of more than 95% for 60 minutes, taking it out and drying it naturally;

[0028] Step 2: Use the ultrasonic thermal reflux extraction and concentration unit (the ultrasonic thermal reflux extraction and concentration unit was purchased from Qihe Luli Pharmaceutical Chemical Equipment Installation Engineering Co., Ltd.) to extract the dried raw medicinal materials in step 1 respectively, and extract the extracted After the product is mixed, it is made into a powder with a particle size of 200-300 mesh;

[0029] Step 3, make the powder described in step 2 into thrombolytic powder according to the conventional method for making ...

Embodiment 2

[0031] The raw materials used in this embodiment are 25g of Panax notoginseng, 25g of Rhizoma Chuanxiong, 25g of hippocampus, and 10g of pangolin.

[0032] The preparation method of the present embodiment is as follows:

[0033] Step 1, taking each raw medicinal material by weight, soaking the weighed raw medicinal material with alcohol with a mass concentration of 95% or more for 30 minutes, taking it out and drying it naturally;

[0034] Step 2: Use the ultrasonic thermal reflux extraction and concentration unit (the ultrasonic thermal reflux extraction and concentration unit was purchased from Qihe Luli Pharmaceutical Chemical Equipment Installation Engineering Co., Ltd.) to extract the dried raw medicinal materials in step 1 respectively, and extract the extracted After the product is mixed, it is made into a powder with a particle size of 200-300 mesh;

[0035] Step 3. Press the powder described in step 2 into tablets according to the conventional tablet-making method to...

Embodiment 3

[0037] The raw materials used in this example are 15g of Panax notoginseng, 15g of Rhizoma Chuanxiong, 15g of hippocampus, and 6g of pangolin.

[0038] The preparation method of the present embodiment is as follows:

[0039] Step 1, taking each raw medicinal material by weight, soaking the weighed raw medicinal material with alcohol with a mass concentration of 95% or more for 40 minutes, taking it out and drying it naturally;

[0040] Step 2: Use the ultrasonic thermal reflux extraction and concentration unit (the ultrasonic thermal reflux extraction and concentration unit was purchased from Qihe Luli Pharmaceutical Chemical Equipment Installation Engineering Co., Ltd.) to extract the dried raw medicinal materials in step 1 respectively, and extract the extracted After the product is mixed, it is made into a powder with a particle size of 200-300 mesh;

[0041] Step 3, the powder described in step 2 is made into thrombus-dissolving pills according to the conventional method ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Chinese medicinal composition for preventing and treating cardiovascular, cerebrovascular and renovascular diseases. The Chinese medicinal composition is prepared from the following Chinese herbal medicines in part by weight: 10 to 25 parts of notoginseng root, 10 to 25 parts of szechuan lovage rhizome, 10 to 25 parts of sea horse and 3 to 10 parts of pangolin scales. In addition, the invention also discloses a preparation method for the Chinese medicinal composition. The Chinese medicinal composition is safe and convenient to use, and does not have toxic or side effect; and compared with the conventional 'Chinese patent medicine', the Chinese medicinal composition has the advantages that a curative effect is reliable and obvious; hemorrhagic diseases (the thrombocytopenic problem) are not caused when the Chinese medicinal composition is used; the Chinese medicinal composition has the effects of promoting blood circulation, eliminating stasis (dissolving thrombus), promoting qi circulation and blood (removing thrombus), dispelling wind and dredging collaterals, and mainly has the double effects of dissolving 'thrombus' quickly, softening blood vessels, dissolving thrombus and stopping bleeding; and an effect of improving cardio-cerebral renal microcirculation is obvious, syndromes which occur before cardiovascular, cerebrovascular and renovascular diseases come on can be prevented and treated fundamentally, senility can be delayed, and the total effective rate is more than 97 percent.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition for preventing and treating cardiovascular, cerebrovascular and kidney diseases and a preparation method thereof. Background technique [0002] Cardiovascular and cerebrovascular disease is a common disease that seriously endangers the health of human beings, especially middle-aged and elderly people over 50 years old. Even if the most advanced and perfect treatment methods are applied, more than 50% of the survivors of cerebrovascular accidents still cannot survive. Take care of yourself completely. The number of people who die from cardiovascular, cerebrovascular and renal vascular diseases is as high as 15 million every year in the world, ranking first among various causes of death. Nearly 3 million people die from cardiovascular, cerebrovascular and renal vascular diseases in my country every year, accounting for 51% of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/258A61P9/10A61K35/36A61K35/56A61K35/60
Inventor 周保民周洲周立
Owner 周保民
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap